This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIH-NIAID-2180801and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2023-04 June 02, 2023.

The North American Industry Classification System (NAICS) code for this procurement is 325414 - Biological Product (except Diagnostic) Manufacturing. The requirement is being competed with a brand name restriction, and without a small business set-aside.

The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for the following Brand Name Supplies:

Catalog No

Product Name

Quantity

BP-25498

ALC-0315

1x50mg

BP-25499

SM-102

1x50mg

BP-26359

BP Lipid 101

1x50mg

BP-26360

BP Lipid 102

1x50mg

BP-26361

BP Lipid 103

1x50mg

BP-26362

BP Lipid 104

1x50mg

BP-26363

BP Lipid 105

1x50mg

BP-26364

BP Lipid 106

1x50mg

BP-26365

BP Lipid 107

1x50mg

BP-26367

BP Lipid 109

1x50mg

BP-26370

BP Lipid 112

1x50mg

BP-26371

BP Lipid 113

1x50mg

BP-26372

BP Lipid 114

1x50mg

BP-26373

BP Lipid 116

1x50mg

BP-26374

BP Lipid 117

1x50mg

BP-26375

BP Lipid 118

1x50mg

BP-26377

BP Lipid 120

1x50mg

BP-26379

BP Lipid 122

1x50mg

BP-26380

BP Lipid 123

1x50mg

BP-26381

BP Lipid 124

1x50mg

BP-26383

BP Lipid 126

1x50mg

BP-26466

BP Lipid 209

1x50mg

BP-26468

BP Lipid 211

1x50mg

BP-26469

BP Lipid 212

1x50mg

BP-26471

BP Lipid 214

1x50mg

BP-26485

BP Lipid 128

1x50mg

BP-26386

BP Lipid 129

1x50mg

BP-26388

BP Lipid 131

1x50mg

BP-26390

BP Lipid 133

1x50mg

BP-26392

BP Lipid 135

1x50mg

BP-26393

BP Lipid 136

1x50mg

BP-26395

BP Lipid 138

1x50mg

BP-26397

BP Lipid 140

1x50mg

BP-26399

BP Lipid 142

1x50mg

BP-26403

BP Lipid 146

1x50mg

BP-26408

BP Lipid 151

1x50mg

BP-27892

BP Lipid 226

1x50mg

BP-27893

BP Lipid 216

1x50mg

BP-27894

BP Lipid 217

1x50mg

BP-27895

BP Lipid 218

1x50mg

BP-27896

BP Lipid 219

1x50mg

BP-27897

BP Lipid 220

1x50mg

BP-27898

BP Lipid 221

1x50mg

BP-27899

BP Lipid 222

1x50mg

BP-27900

BP Lipid 223

1x50mg

BP-27901

BP Lipid 224

1x50mg

BP-27902

BP Lipid 225

1x50mg

BP-26368

BP Lipid 110

1x50mg

BP-26369

BP Lipid 111

1x50mg

BP-26378

BP Lipid 121

1x50mg

BP-26382

BP Lipid 125

1x50mg

BP-26384

BP Lipid 127

1x50mg

BP-26467

BP Lipid 210

1x50mg

BP-26470

BP Lipid 213

1x50mg

BP-26387

BP Lipid 130

1x50mg

BP-26389

BP Lipid 132

1x50mg

BP-26391

BP Lipid 134

1x50mg

BP-26394

BP Lipid 137

1x50mg

BP-26396

BP Lipid 139

1x50mg

BP-26398

BP Lipid 141

1x50mg

BP-26400

BP Lipid 143

1x50mg

BP-26401

BP Lipid 144

1x50mg

BP-26402

BP Lipid 145

1x50mg

BP-26404

BP Lipid 147

1x50mg

BP-26405

BP Lipid 148

1x50mg

BP-26406

BP Lipid 149

1x50mg

BP-26407

BP Lipid 150

1x50mg

BP-26409

BP Lipid 152

1x50mg

BP-26410

BP Lipid 153

1x50mg

BP-26411

BP Lipid 154

1x50mg

Place of Performance: NIH, 9 West Watkins Mill Road, Gaithersburg, MD 20878, United States. FOB: Destination

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following: technical capability to meet the requirements and price.

The following FAR provisions apply to this acquisition:

FAR 52.212-1 Instructions to Offerors Commercial Items (MAR 2023)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (DEC 2022)

FAR 52.204-7 System for Award Management (OCT 2018)

(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)

FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)

FAR 52.204–26 Covered Telecommunications Equipment or Services-Representation

(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26

The following FAR contract clauses apply to this acquisition:

FAR 52-212-4 Contract Terms and Conditions Commercial Items (DEC 2022)

FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (JUN 2023)

*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)

FAR 52.204-13 System for Award Management Maintenance (OCT 2018)

FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (DEC 2015)

52.252-2 -- Clauses Incorporated by Reference. (FEB 1998)

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.

Offers may be e-mailed to Margaret Schott (E-Mail/ margaret.schott@nih.gov). Offers shall include RFQ number in the subject line (RFQ-NIH-NIAID-2180801). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)

All responsible sources may submit an offer that will be considered by this Agency.

Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Margaret Schott.

Attachments/Links